TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36050727

Group type: EXPERIMENTAL
Intervention: Educational intervention based on BASNEF model, 14 training sessions of 60 minutes each.
Number of subjects: 202

Group type: COMPARATOR
Intervention: Control group (no educational intervention).
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Educational intervention based on BASNEF model.
Number of subjects: 202
Study: 36059199

Group type: EXPERIMENTAL
Intervention: Prenatal breast-feeding education on 'safe breastfeeding in the COVID-19 pandemic'
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Prenatal breast-feeding education
Number of subjects: 128
Study: 34617003

Group type: EXPERIMENTAL
Intervention: standard-dose CS
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: standard-dose CS plus EEN (Modulen 1.5 kcal)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: short-course CS plus EEN
Number of subjects: 100

Group type: COMPARATOR
Intervention: CS alone
Number of subjects: 100
Study: 32545539

Group type: EXPERIMENTAL
Intervention: Intervention small group social networks (10 participants, 12 weekly sessions)
Number of subjects: 261
Study: 34894034

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 33362171

Group type: EXPERIMENTAL
Intervention: Patient-reported outcomes (PROs) questionnaire, filled before each visit
Number of subjects: 211

Group type: COMPARATOR
Intervention: Usual visits (Control group A)
Number of subjects: 211
Study: 93082162

Group type: EXPERIMENTAL
Intervention: Prednisone priming followed by alpha-interferon 2A
Number of subjects: 9
Study: 36064745

Group type: EXPERIMENTAL
Intervention: LinkUP intervention (tailored education, motivational interviewing, and problem-solving strategies)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Didactic attention-control condition (information sharing only)
Number of subjects: 0
Study: 34245666

Group type: EXPERIMENTAL
Intervention: Estetrol (E4) 15 mg and drospirenone (DRSP) 3 mg
Number of subjects: 1553
Study: 34671976

Group type: EXPERIMENTAL
Intervention: Finger prick and look at blood
Number of subjects: 126

Group type: COMPARATOR
Intervention: Finger prick and not look at blood
Number of subjects: 126

Group type: COMPARATOR
Intervention: Sham finger prick
Number of subjects: 126
Study: 36075994

Group type: EXPERIMENTAL
Intervention: S1 maintenance therapy (MT)
Number of subjects: 183

Group type: COMPARATOR
Intervention: non-maintenance therapy (non-MT)
Number of subjects: 183
Study: 35725414

Group type: EXPERIMENTAL
Intervention: Partial vertebrae body radiotherapy
Number of subjects: 66

Group type: COMPARATOR
Intervention: Whole vertebrae body radiotherapy
Number of subjects: 66
Study: 33596155

Group type: EXPERIMENTAL
Intervention: Exercise against a resistive load during repetitive short squeeze contractions
Number of subjects: 12

Group type: COMPARATOR
Intervention: Exercise without a load during repetitive short squeeze contractions
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Long squeeze contraction against a load
Number of subjects: 12

Group type: COMPARATOR
Intervention: Long squeeze contraction without a load
Number of subjects: 12
Study: 32929634

Group type: EXPERIMENTAL
Intervention: Elderberry extract (15 ml orally twice a day for 5 days for ages 5-12; 15 ml 4 times a day for 5 days for > 12 years)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 36242718

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (mean dose at week 8: 38.1 mg for Rollover; 36.5 mg for Switch)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (mean dose across cohorts after titration: 37.6 mg; final visit mean dose: 45.7 mg)
Number of subjects: 119
Study: 32448712

Group type: COMPARATOR
Intervention: Moderate intensity exercise (EX)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 413
Study: 36125505

Group type: EXPERIMENTAL
Intervention: Adjuvant pembrolizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (KEYNOTE-564)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients with pN1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients without LNI but with necrosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Patients without LNI and necrosis
Number of subjects: 0
Study: 34130688

Group type: EXPERIMENTAL
Intervention: Mistletoe extract (Abnoba Viscum Q®) administered subcutaneously during chemoradiotherapy.
Number of subjects: 52
Study: 35094827

Group type: EXPERIMENTAL
Intervention: Solution-Oriented Therapy Programme (6 to 10 sessions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 0
Study: 33653361

Group type: EXPERIMENTAL
Intervention: Group training
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Training through booklet
Number of subjects: 81

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 81
Study: 35756985

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham Inspiratory Muscle Training (sham-IMT)
Number of subjects: 20
Study: 32717139

Group type: EXPERIMENTAL
Intervention: Genetically predicted serum IGF-1 levels
Number of subjects: 416
Study: 34383607

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg per kg of body mass)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (cellulose)
Number of subjects: 11
Study: 33626213

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment (0.03%) application twice/day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Microneedling once/week and tacrolimus ointment application directly after microneedling and twice/day the rest of the week
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Microneedling once/week alone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Tacrolimus ointment application twice/day under occlusion by polyethylene foil
Number of subjects: 20
Study: 32711546

Group type: EXPERIMENTAL
Intervention: Aggressive body temperature management (nasopharyngeal temperature 36.61 ± 0.18 °C)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard body temperature management (35.80 ± 0.18 °C)
Number of subjects: 70
Study: 36416303

Group type: EXPERIMENTAL
Intervention: Group-Early Start Denver Model (G-ESDM) in inclusive classrooms
Number of subjects: 58

Group type: COMPARATOR
Intervention: Group-Early Start Denver Model (G-ESDM) in specialised classrooms
Number of subjects: 58
Study: 34265007

Group type: EXPERIMENTAL
Intervention: Lorcaserin 20 mg
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 32998940

Group type: EXPERIMENTAL
Intervention: LNG‐IUS
Number of subjects: 25
Study: 616616941

Group type: EXPERIMENTAL
Intervention: Transition Preparation Training Program (TPT)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study: 36409386

Group type: EXPERIMENTAL
Intervention: Brief intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive intervention
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Any intervention arm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 34450192

Group type: EXPERIMENTAL
Intervention: REDUCE-IT eligible group
Number of subjects: 62464
Study: 35195201

Group type: EXPERIMENTAL
Intervention: Chagas disease patients with undernutrition
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Chagas disease patients with hospital discharge
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (other etiologies)
Number of subjects: 131
Study: 32804345

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation (500 UI/kg p.o. weekly)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Observation (− D)
Number of subjects: 30
Study: 32688398

Group type: EXPERIMENTAL
Intervention: LIA with steroids (triamcinolone)
Number of subjects: 45

Group type: COMPARATOR
Intervention: LIA without steroids
Number of subjects: 45
Study: 32644829

Group type: EXPERIMENTAL
Intervention: Ischemic stroke patients (IS)
Number of subjects: 230

Group type: COMPARATOR
Intervention: CYP2C19 metabolizers (intermediate and poor)
Number of subjects: 230

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 230
Study: 35068454

Group type: EXPERIMENTAL
Intervention: Plasma L-carnitine
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: L-carnitine addition to conventional risk factors
Number of subjects: 617

Group type: EXPERIMENTAL
Intervention: Higher L-carnitine and lower inflammatory status
Number of subjects: 617
Study: 33188651

Group type: EXPERIMENTAL
Intervention: Endoscopically assisted extracapsular dissection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Open parotidectomy
Number of subjects: 50
Study: 35631283

Group type: EXPERIMENTAL
Intervention: Endobarrier insertion
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Lifestyle modification with Endobarrier
Number of subjects: 47

Group type: COMPARATOR
Intervention: Lifestyle modification without Endobarrier
Number of subjects: 47
Study: 33236509

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 48
Study: 35559855

Group type: EXPERIMENTAL
Intervention: Essential Coaching for Every Mother program (text messages related to newborn and maternal care for 6 weeks)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Essential Coaching for Every Mother program (text messages)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 150
Study: 33248462

Group type: EXPERIMENTAL
Intervention: Automatic CRTd optimization (n=93)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Echocardiography‐guided CRTd optimization (n=98)
Number of subjects: 191
Study: 35694945

Group type: EXPERIMENTAL
Intervention: Exoskeleton on, 'locking tendency' 0% (On_LT0)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Exoskeleton on, 'locking tendency' 85% (On_LT85)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Exoskeleton off (Off)
Number of subjects: 22
Study: 32306462

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine, vitamin E, and vitamin C (NEC)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 35
Study: 33596854

Group type: EXPERIMENTAL
Intervention: Shared decision making (SDM) counseling session
Number of subjects: 78
Study: 32237275

Group type: EXPERIMENTAL
Intervention: RAM cannula
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Hudson prongs
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Nasal mask
Number of subjects: 90
Study: 34193434

Group type: EXPERIMENTAL
Intervention: Plan Well Guide (immediate intervention)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Delayed intervention (3-month wait period)
Number of subjects: 90
Study: 32740320

Group type: EXPERIMENTAL
Intervention: Cuff pressure of 20 cmH2O (CP20)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Cuff pressure of 60 cmH2O (CP60)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Continuous positive airway pressure
Number of subjects: 184

Group type: COMPARATOR
Intervention: Intermittent positive airway pressure
Number of subjects: 184
Study: 32604288

Group type: EXPERIMENTAL
Intervention: Bilateral regional maxillary nerve block (MNB) with 0.15 ml/kg of lidocaine clorhidrate 2% with epinephrine 1:50.000, under direct vision through the spheno palatine holes, before surgery.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Traditional general anesthesia plus local anesthesia (used in Hospital B).
Number of subjects: 60
Study: 33601862

Group type: EXPERIMENTAL
Intervention: Stenosis group (28 patients)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Control group (60 patients)
Number of subjects: 88
Study: 33813628

Group type: EXPERIMENTAL
Intervention: Septoplasty (SPL)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Septorhinoplasty (SRP)
Number of subjects: 73
Study: 36409508

Group type: EXPERIMENTAL
Intervention: VR distraction using a domed ceiling screen
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard care (no VR)
Number of subjects: 88
Study: 33588639

Group type: EXPERIMENTAL
Intervention: Living Well self-management intervention
Number of subjects: 15
Study: 32053988

Group type: EXPERIMENTAL
Intervention: Intermittent Calorie Restriction (ICR)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Continuous Calorie Restriction (CCR)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Overall weight loss
Number of subjects: 150
Study: 616497285

Group type: EXPERIMENTAL
Intervention: High retention enema with Chaishao Chengqi decoction modified with salvia miltiorrhiza
Number of subjects: 83

Group type: COMPARATOR
Intervention: Routine treatments (fasting, rehydration, acid suppression, inhibition of pancreatic enzyme activity, use of antibiotics)
Number of subjects: 83
Study: 33731586

Group type: EXPERIMENTAL
Intervention: Hemoclips
Number of subjects: 298

Group type: COMPARATOR
Intervention: APC
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Hemoclips monotherapy
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Hemoclips combination therapy
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Hemoclips combination therapy (in antithrombotic subgroup)
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Hemoclips combination therapy (after propensity score matching)
Number of subjects: 298
Study: 34351478

Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis with alteplase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32348985

Group type: EXPERIMENTAL
Intervention: 1,000 mg IV ferric derisomaltose
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 35028890

Group type: EXPERIMENTAL
Intervention: High Dose Group (HDG) - 3750 IU VD3/day
Number of subjects: 248

Group type: COMPARATOR
Intervention: Low Dose Group (LDG) - 600 IU VD3/day
Number of subjects: 248
Study: 33406285

Group type: EXPERIMENTAL
Intervention: Return to formula low-energy-diet (LED)
Number of subjects: 123

Group type: COMPARATOR
Intervention: No return to formula low-energy-diet (RT)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Participants never recorded as having regained >2 kg or using RTs
Number of subjects: 123
Study: 32870242

Group type: EXPERIMENTAL
Intervention: Cord blood transplantation
Number of subjects: 368

Group type: COMPARATOR
Intervention: Haploidentical transplantation
Number of subjects: 368
Study: 36442824

Group type: EXPERIMENTAL
Intervention: ECG Belt system (EBS) for CRT implantation and programming
Number of subjects: 408

Group type: COMPARATOR
Intervention: Standard CRT care
Number of subjects: 408
Study: 33880021

Group type: EXPERIMENTAL
Intervention: PNF stretching combined with aerobic training (10-minute PNF stretching 3 times every training day for 6 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Aerobic training (30 min on a treadmill, 5 days per week for 6 weeks)
Number of subjects: 55
Study: 32151570

Group type: EXPERIMENTAL
Intervention: Enhanced follow-up protocol
Number of subjects: 162

Group type: COMPARATOR
Intervention: Standard follow-up protocol
Number of subjects: 162
Study: 35134817

Group type: EXPERIMENTAL
Intervention: Amlodipine-HCTZ
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: Amlodipine-Perindopril
Number of subjects: 635

Group type: COMPARATOR
Intervention: Perindopril-HCTZ
Number of subjects: 635

Group type: EXPERIMENTAL
Intervention: 24-hour ambulatory BP monitoring
Number of subjects: 635
Study: 34950225

Group type: EXPERIMENTAL
Intervention: Parent training (PT)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Parent education (PE)
Number of subjects: 168
Study: 35853995

Group type: EXPERIMENTAL
Intervention: Crowdsourced HBV/HCV promotion materials through social media
Number of subjects: 750

Group type: COMPARATOR
Intervention: Facility-based care without promotional materials
Number of subjects: 750
Study: 32316070

Group type: EXPERIMENTAL
Intervention: Ixekizumab (IXE) Q4W
Number of subjects: 171

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 171
Study: 35017261

Group type: EXPERIMENTAL
Intervention: Cigarette packs with background colour and capsule image
Number of subjects: 2450

Group type: EXPERIMENTAL
Intervention: Cigarette packs named 'Tropical Burst'
Number of subjects: 2450

Group type: EXPERIMENTAL
Intervention: Cigarette packs named 'Arctic Air'
Number of subjects: 2450

Group type: EXPERIMENTAL
Intervention: Cigarette packs displaying a flavour name, background colour or capsule image
Number of subjects: 2450
Study: 34125811

Group type: EXPERIMENTAL
Intervention: Prenatal educational intervention (five group and three individual sessions on feeding practices)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine care (at least three prenatal consultations)
Number of subjects: 60
Study: 32323560

Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention for 12 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 24
Study: 34826166

Group type: EXPERIMENTAL
Intervention: Cervical pessary
Number of subjects: 408

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 408
Study: 32543461

Group type: EXPERIMENTAL
Intervention: Sentinel City®3.0 virtual simulation program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional clinical placements (agencies or geographical neighbourhoods)
Number of subjects: 0
Study: 616451442

Group type: EXPERIMENTAL
Intervention: dSM265
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 35968208

Group type: EXPERIMENTAL
Intervention: Symbiotic (Pedilact) - 5 drops containing Lactobacillus reuteri and simethicone (20 mg twice daily) for 4 weeks
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo with simethicone for 4 weeks
Number of subjects: 76
Study: 35099283

Group type: EXPERIMENTAL
Intervention: Bioimpedance spectroscopy (BIS)
Number of subjects: 1200

Group type: COMPARATOR
Intervention: Tape measurement (TM)
Number of subjects: 1200

Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 1200
Study: 32604427

Group type: EXPERIMENTAL
Intervention: Successful ultrasound-accelerated catheter-directed thrombolysis (UACDT)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Standard treatment (control)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Successful UACDT
Number of subjects: 152
Study: 35075138

Group type: EXPERIMENTAL
Intervention: Capecitabine chemotherapy alone or in combination with bevacizumab (± mitomycin C)
Number of subjects: 325
Study: 33602996

Group type: EXPERIMENTAL
Intervention: BIAsp 30 plus metformin
Number of subjects: 2

Group type: COMPARATOR
Intervention: BIAsp 30
Number of subjects: 2
Study: 34552008

Group type: EXPERIMENTAL
Intervention: Anthracyclines plus ifosfamide
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Doxorubicin plus palifosfamide with MRP-1 inhibitors (nilotinib or avapritinib)
Number of subjects: 231

Group type: COMPARATOR
Intervention: MRP-1 inhibitors (nilotinib, ripretinib, selumetinib, avapritinib)
Number of subjects: 231
Study: 36389149

Group type: EXPERIMENTAL
Intervention: Nomogram for predicting 80-day survival
Number of subjects: 331
Study: 35110894

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PECS I (0.2 ml/kg) and PECS II (0.4 ml/kg) block, post-induction with 0.25% levobupivacaine, maximum dose of 2 mg/kg.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PECS I and II block
Number of subjects: 60

Group type: COMPARATOR
Intervention: No block, only general anesthesia
Number of subjects: 60
Study: 32278103

Group type: EXPERIMENTAL
Intervention: Increased abdominal pressure using a 3000 ml bag of normal saline (NS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No special treatment (Control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 34997248

Group type: EXPERIMENTAL
Intervention: Accelerometer-based navigation (ABN)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Computer-assisted navigation (CAN)
Number of subjects: 50
Study: 35341689

Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel CAR-T therapy
Number of subjects: 0
Study: 32545026

Group type: EXPERIMENTAL
Intervention: Selenium in Multimicronutrient (MMN)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Iron and Folic Acid (IFA)
Number of subjects: 32
Study: 35869526

Group type: EXPERIMENTAL
Intervention: Favipiravir plus nitazoxanide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Favipiravir plus nitazoxanide placebo
Number of subjects: 0
Study: 33764470

Group type: EXPERIMENTAL
Intervention: MEDi® robot intervention with standard care (SC) and Ametop©
Number of subjects: 137

Group type: COMPARATOR
Intervention: Standard care (SC) with Ametop© only
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: MEDi® robot intervention
Number of subjects: 137
Study: 32251038

Group type: EXPERIMENTAL
Intervention: Tai Chi intervention
Number of subjects: 17
Study: 34489296

Group type: EXPERIMENTAL
Intervention: Identification of appropriate patients for deprescribing
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Patient education
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: General practitioners (GP) education
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Development and use of a tapering schedule
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Engage practice staff in education and appropriate identification of patients
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Provide feedback to staff about deprescribing occurrences within the practice
Number of subjects: 50
Study: 32492138

Group type: EXPERIMENTAL
Intervention: 150 mg/d of resveratrol (n = 20)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo (n = 21)
Number of subjects: 41